Company Information

Company nameAptahem AB
Business strategyAptahem AB is a biotechnology company that develops aptamer-based pharmaceuticals for the treatment of acute, life-threatening conditions in which a combination of coagulation, inflammation and tissue damage are involved. The company also performs business development activities to identify future collaboration partners and licensing partners. The company’s lead candidate Apta-1 is being developed as an emergency medicine intended to prevent the onset of life-threatening organ and tissue damage in sepsis patients.
CEOMikael Lindstam
Chairman of the BoardBert Junno
BoardBert Junno, Theresa Comiskey Olsen, Johan Lindh, Mikael Lindstam
Organisation number556970-5782
Articles of AssociationArticles of Association 2023-06-07. See link below to download (in Swedish)
AddressNorra Vallgatan 58
Zip code211 22
Telephone0766-02 01 99

Download the Articles of Association as pdf (in Swedish)